Department of Radiation Oncology, University of California, San Francisco, United States.
University of Maryland Medical Center, Baltimore, United States.
Radiother Oncol. 2017 Dec;125(3):392-397. doi: 10.1016/j.radonc.2017.10.014. Epub 2017 Nov 20.
Clinical decision support systems are a growing class of tools with the potential to impact healthcare. This study investigates the construction of a decision support system through which clinicians can efficiently identify which previously approved historical treatment plans are achievable for a new patient to aid in selection of therapy.
Treatment data were collected for early-stage lung and postoperative oropharyngeal cancers treated using photon (lung and head and neck) and proton (head and neck) radiotherapy. Machine-learning classifiers were constructed using patient-specific feature-sets and a library of historical plans. Model accuracy was analyzed using learning curves, and historical treatment plan matching was investigated.
Learning curves demonstrate that for these datasets, approximately 45, 60, and 30 patients are needed for a sufficiently accurate classification model for radiotherapy for early-stage lung, postoperative oropharyngeal photon, and postoperative oropharyngeal proton, respectively. The resulting classification model provides a database of previously approved treatment plans that are achievable for a new patient. An exemplary case, highlighting tradeoffs between the heart and chest wall dose while holding target dose constant in two historical plans is provided.
We report on the first artificial-intelligence based clinical decision support system that connects patients to past discrete treatment plans in radiation oncology and demonstrate for the first time how this tool can enable clinicians to use past decisions to help inform current assessments. Clinicians can be informed of dose tradeoffs between critical structures early in the treatment process, enabling more time spent on finding the optimal course of treatment for individual patients.
临床决策支持系统是一类具有潜在影响医疗保健的新兴工具。本研究旨在构建一个决策支持系统,通过该系统,临床医生可以高效地识别新患者中哪些先前批准的历史治疗方案是可行的,以帮助选择治疗方案。
收集了早期肺癌和术后口咽癌患者接受光子(肺部和头颈部)和质子(头颈部)放疗的治疗数据。使用患者特定的特征集和历史计划库构建了机器学习分类器。使用学习曲线分析模型准确性,并研究了历史治疗计划匹配。
学习曲线表明,对于这些数据集,对于早期肺癌的放射治疗,需要大约 45、60 和 30 名患者,才能获得足够准确的分类模型;对于术后口咽部光子放疗和术后口咽部质子放疗,分别需要 45、60 和 30 名患者。由此产生的分类模型提供了一个可用于新患者的先前批准治疗计划的数据库。提供了一个示例案例,突出了在保持靶剂量不变的情况下,两个历史计划中心脏和胸壁剂量之间的权衡。
我们报告了第一个基于人工智能的临床决策支持系统,该系统将患者与放射肿瘤学中的过去离散治疗计划联系起来,并首次展示了该工具如何使临床医生能够利用过去的决策来帮助当前评估。临床医生可以在治疗过程早期了解关键结构之间的剂量权衡,从而有更多的时间为个体患者找到最佳治疗方案。